NasdaqCM:ASPI
NasdaqCM:ASPIChemicals

ASP Isotopes (ASPI) Is Down 6.8% After Deeper Losses Despite Revenue Growth in Q3 Results - Has The Bull Case Changed?

ASP Isotopes Inc. recently reported earnings for the third quarter and nine months ended September 30, 2025, showing revenue growth to US$4.89 million in the quarter but a net loss of US$12.87 million. Despite higher revenue year-over-year, the increase in net loss and basic loss per share highlights ongoing financial pressures facing the company. We'll examine how the considerable increase in net losses informs ASP Isotopes' current investment narrative and key investor concerns. The end of...
NasdaqCM:CMPX
NasdaqCM:CMPXBiotechs

Compass Therapeutics (CMPX) Up 9.0% After Advancing Oncology Pipeline Updates at Key Healthcare Conference

At the Piper Sandler 37th Annual Healthcare Conference in New York, Compass Therapeutics provided updates on its oncology pipeline, including progress for investigational candidates CTX-10726 and tovecimig. Analyst commentary highlighted the company's strong preclinical and early clinical results, with management reiterating timelines for key data releases and a possible first regulatory filing in 2026. We'll explore how investor enthusiasm for Compass Therapeutics' advancing pipeline,...
NYSE:AMRC
NYSE:AMRCConstruction

Ameresco (AMRC): Exploring the Current Valuation After a Week of Renewed Share Price Momentum

Ameresco (AMRC) shares have gained 1% over the past day and are up nearly 7% for the week. Investors may be watching the stock after its recent month of volatility, looking for cues about its direction ahead. See our latest analysis for Ameresco. Ameresco’s 90-day share price return of 37.3% shows how quickly momentum can build following recent volatility. Its 1-year total shareholder return stands at 21.7%. Short-term swings hint at renewed optimism, but the longer view reminds us just how...
NasdaqGS:ANAB
NasdaqGS:ANABBiotechs

Jemperli Royalty Dispute Could Be a Game Changer for AnaptysBio (ANAB)

In late November 2025, AnaptysBio and GSK/Tesaro initiated competing lawsuits in Delaware Chancery Court, each accusing the other of breaching their collaboration and exclusive license agreement involving the oncology drug Jemperli. This legal conflict places the terms surrounding milestone and royalty payments, exclusivity rights, and the ongoing commercial development of Jemperli at the center of uncertainty for both parties. We'll examine how the dispute over Jemperli's exclusivity and...
NYSE:XZO
NYSE:XZOSoftware

Undervalued Small Caps With Insider Action Across Regions

As December begins, the U.S. stock market has experienced a pullback, with major indices like the Dow Jones and S&P 500 closing lower amid a risk-off sentiment that also affected big tech and crypto-tied shares. Despite these broader market challenges, small-cap stocks often present unique opportunities for investors due to their potential for growth and innovation in diverse sectors. In this landscape, identifying companies with strong fundamentals and strategic insider actions can provide...
NYSE:XZO
NYSE:XZOSoftware

High Growth Tech Stocks In The US Market To Watch

As the United States market enters December with a downturn in major indices like the Dow Jones, S&P 500, and Nasdaq due to risk-off sentiment impacting big tech and crypto-tied shares, investors are closely monitoring high growth opportunities within the tech sector. In this environment of fluctuating market conditions, identifying stocks with strong innovation potential and resilience can be crucial for those looking to navigate the complexities of today's investment landscape.
NasdaqGS:SMCI
NasdaqGS:SMCITech

3 Stocks Estimated To Be Trading Below Their Intrinsic Value In December 2025

As December 2025 begins, the U.S. stock market faces a pullback with major indices like the Dow Jones, S&P 500, and Nasdaq closing lower amid a risk-off sentiment affecting big tech and crypto-tied shares. In such an environment, identifying stocks that are potentially trading below their intrinsic value can offer investors opportunities to capitalize on mispricings in the market.
NasdaqGS:TMC
NasdaqGS:TMCMetals and Mining

Astera Labs And 2 Other Top Growth Companies With Significant Insider Stakes

As the U.S. stock market navigates a challenging start to December, with major indices like the Dow Jones and Nasdaq experiencing declines amid risk-off sentiment, investors are increasingly focused on companies where insiders hold significant stakes. In such volatile times, growth companies with high insider ownership can offer a measure of confidence, as these insiders often have a vested interest in steering their firms toward long-term success.
NasdaqGS:NMRA
NasdaqGS:NMRAPharmaceuticals

Promising Penny Stocks To Watch In December 2025

As December trading begins, major U.S. stock indexes have pulled back, with big tech and cryptocurrency-tied shares experiencing declines amid a risk-off sentiment. Despite the broader market volatility, penny stocks continue to attract attention for their potential to offer growth opportunities at lower price points. Although the term "penny stocks" may seem outdated, these investments often represent smaller or newer companies that can provide significant value when backed by strong...
NasdaqGM:YB
NasdaqGM:YBInsurance

US Market's 3 Undiscovered Gems with Promising Potential

As the United States market navigates a risk-off sentiment with major indices like the Dow Jones, S&P 500, and Nasdaq experiencing declines at the start of December, investors are increasingly cautious about big tech and cryptocurrency-tied shares. In such an environment, small-cap stocks often present intriguing opportunities for those looking to uncover potential growth stories that might be overlooked amidst broader market volatility. Identifying these undiscovered gems requires a keen eye...
NYSE:COP
NYSE:COPOil and Gas

3 Reliable Dividend Stocks To Consider With Up To 9.9% Yield

As the U.S. stock market faces a downturn with major indices like the Dow Jones and S&P 500 closing lower amid risk-off sentiment, investors are increasingly seeking stability through dividend stocks. In this environment, reliable dividend-paying companies can offer a steady income stream, making them an attractive option for those looking to balance their portfolios against market volatility.